SSS17

DRUG4 trials

Sponsors

Shenyang Sunshine Pharmaceutical Co., LTD.

Conditions

Anemia in Chronic Kidney DiseasesAnemia in Pre-Dialysis PatientsHealthy Subjects (HS)

Phase 1

A Study of SSS17 in Healthy Subjects

Shenyang Sunshine Pharmaceutical Co., LTD.Anemia in Chronic Kidney Diseases

Start: 2020-05-01End: 2021-12-31Target: 65Updated: 2020-03-23

A Phase 1 Study of SSS17 in Healthy Subjects.

Shenyang Sunshine Pharmaceutical Co., LTD.Anemia in Chronic Kidney Diseases

Start: 2021-07-26End: 2023-06-30Target: 76Updated: 2022-01-13

A Study Evaluating the Food Effect on the Pharmacokinetics of SSS17 Capsules in Chinese Healthy Subjects

CompletedNCT07024888

Shenyang Sunshine Pharmaceutical Co., LTD.Healthy Subjects (HS)

Start: 2025-03-16End: 2025-05-28Updated: 2025-06-18

Phase 2

Phase II Dose-Finding of Oral SSS17 for Anemia in Non-Dialysis CKD

CompletedNCT07014631

Shenyang Sunshine Pharmaceutical Co., LTD.Anemia in Pre-Dialysis Patients

Start: 2023-03-01End: 2025-04-08Updated: 2025-06-18